mezlocillin has been researched along with probenecid in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
De Schepper, PJ; Tjandramaga, TB; Verbesselt, R; Verbist, L | 2 |
Khan, MH; Tomkyns, JG | 1 |
3 trial(s) available for mezlocillin and probenecid
Article | Year |
---|---|
Mezlocillin pharmacokinetics. Comparison with ampicillin and influence of probenecid.
Topics: Adult; Ampicillin; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male; Mezlocillin; Penicillins; Probenecid | 1979 |
A controlled study of mezlocillin in uncomplicated acute gonorrhoea.
Topics: Ampicillin; Clinical Trials as Topic; Drug Therapy, Combination; Drug Tolerance; Female; Gonorrhea; Humans; Male; Mezlocillin; Penicillin G Procaine; Penicillin Resistance; Penicillins; Probenecid | 1982 |
[Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
Topics: Adult; Ampicillin; Drug Interactions; Humans; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male; Mezlocillin; Penicillins; Probenecid | 1982 |
4 other study(ies) available for mezlocillin and probenecid
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |